The APS Phenotyping Study
Eligible age
18+ yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will be available to investigators for future studies of ARDS, sepsis, and/or pneumonia.
Sponsor: Vanderbilt University Medical Center
You may qualify if…
- ✓ To be eligible for enrollment, a patient must meet all the following inclusion criteria at the time of the first study-specified biospecimen collection (Time 0):
- ✓ 1. Age ≥ 18 years old
- ✓ 2. Admitted (or planned to be admitted) to an intensive care unit (ICU) or other in-patient hospital location where IV vasopressors or advanced respiratory support (invasive mechanical ventilation, non-invasive ventilation, or high flow nasal cannula) are routinely provided (referred to as an "eligible unit.")
- ✓ 3. Acute cardiovascular or pulmonary organ dysfunction defined by meeting at least one of the two criteria below:
- ✓ New receipt of invasive mechanical ventilation, non-invasive ventilation, high flow nasal cannula, or supplemental oxygen at a flow rate of ≥ 6 lpm for acute hypoxemia.
- ✓ a. Patients who use chronic oxygen therapy are eligible to participate if they are receiving at least 6 lpm higher than their baseline oxygen requirement (e.g., a patient on 3 lpm O2 at baseline is eligible if they require ≥9 lpm for hypoxemia) or are started on advanced respiratory support (invasive mechanical ventilation, non- invasive ventilation, or high flow nasal cannula).
- ✓ Receipt of intravenous infusion of a vasopressor medication for at least one hour.
- ✓ 4. Acute cardiovascular or pulmonary organ dysfunction (inclusion criterion #3) is attributed to an acute inflammatory condition, including but not limited to any of the following:
You may not qualify if…
- ✕ To be eligible for enrollment, a patient must not meet any of the following exclusion criteria at the time of the first study-specified biospecimen collection (Time 0):
- ✕ 1. Patient/legally authorized representative (LAR) declines participation.
- ✕ 2. Acute cardiovascular or pulmonary organ dysfunction (inclusion criterion #3) has been present for \> 48 hours.
- ✕ 3. Patient has been in an eligible unit (inclusion criterion #2) for more than 120 hours (five days).
- ✕ 4. Patient is no longer expected to meet the acute cardiovascular or pulmonary organ dysfunction inclusion criterion (inclusion criterion #3) 24 hours after enrollment.
- ✕ 5. Patient desires comfort measures only.
- ✕ 6. Patient is a prisoner.
- ✕ 7. Patient had out-of-hospital cardiac arrest leading to this hospitalization.
Where it's recruiting
Fresno · Palo Alto · San Francisco
Denver · Loveland
Chicago
Baltimore
Ann Arbor
St Louis
Durham
Cincinnati
Philadelphia
Nashville
Murray · Salt Lake City
Source: ClinicalTrials.gov · NCT06521502 · last updated 2026-02-20